ABSTRACT 0.40 and 0.12, respectively, and were 0.127, 0.097 and 0.028
INTRODUCTION
The MDR1 gene has been associated with resistance to a number of naturally occurring and synthetic drugs in cancer chemotherapy (1, 5, 11) . The gene codes for a 170-kDa glycoprotein (P-gp) that is localized at the plasma membrane. This P-gp functions as an energy-dependent efflux pump, transporting molecules from the interior of the cells to the outside. MDR1 expression has been correlated with the response of hematopoietic malignancies and solid tumors to chemotherapy (7, 8, 10) . Measuring the level of MDR1 expression before cytotoxic therapy, therefore, has important clinical implications including attempts to block MDR with verapamil, cyclosporine A, tamoxifen and second-generation MDR blockers including PSC833 and Dexniguldipine. At present, the most common, fast and powerful method to detect MDR1 expression is polymerase chain reaction (PCR) of MDR1 mRNA following reverse transcription (RT). Among other considerations, the success of quantitative PCR depends on the technique used to detect the amplified products. Because of variations seen with ethidium bromide staining, many laboratories are using radioactivity for detection, whether by direct incorporation, primer labeling, radioactive probes for Southern blots or internal standards (1, 4, 12) . The QPCR-5000 ™method (QPCR; Perkin-Elmer, Norwalk, CT, USA) is a new nonradioactive, non-gel based system that can quantitatively detect PCR products. The QPCR uses an electrochemiluminescence process to detect the presence of a TBR molecule [tris (2,2 ′ -bipyridine) ruthenium (II) chelate], which is a nonradioactive tag that can be placed on the 5 ′ terminus of any PCR primer or probe. This paper reports a comparative study of quantitation between 32 P-dCTP incorporation and the QPCR for quantitative PCR. The MDR1 mRNA, P-gp levels and efflux activities were determined for system cell lines with different amounts of MDR1 mRNA, including 8226/Dox40 and 8226/Dox 6 (resistant), 8226/S (sensitive), CEM Dox1 and three acute myeloid leukemia (AML) patient samples. The results demonstrate that the QPCR method is significantly more advantageous than the 32 P-incorporation method for quantitative detection of PCR products.
MATERIALS AND METHODS

Cells and Cell Culture
Patient samples, obtained from Dr. Cheryl Wilmans, were supplied for the MDR1 Detection Methods Workshop at St. Jude's Children's Research Hospital (Memphis, TN, USA). 8226/Dox40, 8226/Dox6 and CEM Dox1 drug-resistant cell lines, and the 8226/S drug-sensitive parental cell line were cultured in RPMI 1640 medium plus 10% fetal calf serum (FCS), 1% ampicillin and 1% streptomycin. The cells were incubated in a 37°C incubator containing 5% CO 2 .
RNA Isolation and Reverse Transcription
RNA was isolated according to the single-step acid guanidinium thiocyanate-phenol-chloroform method (2) . Purified RNA samples were quantitated using a DU-640 spectrophotometer (Beckman Instruments, Fullerton, CA, USA). A reverse-transcription (RT) kit was used to synthesize cDNA, according to the manufacturer's instructions (Boehringer Mannheim, Indianapolis, IN, USA). One microgram of total RNA template was used per 10 µ L of RT reaction.
Vol. 21, No. 4 (1996) BioTechniques 727 Figure 1 . Quantitation of the MDR1 PCR product by the QPCR and 32 P-labeling methods at various cycle numbers using the Dox40 drug-resistant cell line. PCR reaction tubes that contained the same amount of cDNA template were amplified at 5-40 cycles. The PCR products were quantitated by the two methods (see Materials and Methods).
Primers
MDR1 and β 2 -microglobulin ( β 2 -M) primers (12) were synthesized on an Applied Biosystems oligonucleotide synthesizer (Model 392; Perkin-Elmer/Applied Biosystems Division, Foster City, CA, USA). The TBR-labeled and biotin-labeled primers were obtained from Baron Biotech (Milford, CT, USA). The labeled primers were purified by high-performance liquid chromatography (HPLC).
Amplification and Detection Using 32 P Incorporation
One-tenth of the RT reaction was used for each PCR, for a total volume of 25 µ L. MDR1 and β 2 -M cDNAs were amplified simultaneously in separate 0.2-mL MicroAmp ® tubes (Perkin-Elmer). The conditions for each reaction were as follows: 1.0 µ M primers (each), 0.2 µ L of 25 mM dNTP, 2 µ Ci 32 P-α -dCTP, 2.5 µ L of 10 × PCR buffer and 1.5 U AmpliTaq ® DNA Polymerase (Perkin-Elmer). The thermal cycling was performed in a GeneAmp ® PCR System 9600 (Perkin-Elmer) using the following parameters: 28 cycles of 94°C for 30 s, 63°C for 30 s and 72°C for 45 s, followed by a 10-min postextension step at 72°C. Following thermal cycling, 3.0 µ L of the PCR was analyzed on an 8% polyacrylamide gel. Electrophoresis was performed for 3 h at 300 V. The radioactive products were detected and quantitated on the Betascope ™-603 (Betagen, Waltham, MA, USA) for 30 min, with exposure after on Kodak film (Eastman Kodak, Rochester, NY, USA) at -70°C for 4-8 h without an intensifying screen. All experiments were performed in duplicate.
Amplification and Detection Using the QPCR-5000 System
PCR conditions used were the same as those indicated above, with the exception that the primer concentrations were 0.2 µ M (each) and only 25 cycles were performed. Following PCR, 1 µ L of the reaction was incubated with 49 µ L of 1 × PCR reaction buffer and 15 µ L of QPCR streptavidin-coated ferrous beads (Perkin-Elmer) at room temperature for 20 min. Following this step, 335 µ L of QPCR Assay Buffer (PerkinElmer) were added, and the samples were analyzed using the QPCR-5000 System according to the manufacturer's instructions.
Northern Dot Blot Analysis
Ten micrograms of total RNA were denatured and put on a dot blot manifold. Hybridization was carried out at 42°C for 20 h with a hybridization solution containing 50% formamide, 1% Denhardt's, 5 ×sodium chloride-sodium phosphate-EDTA (SSPE), 0.5% dextran sulfate, 0.5% sodium dodecyl sulfate (SDS) and 200 µ g/mL salmon sperm DNA. The MDR1 and β -actin probes were obtained from Oncor (Gaithersburg, MD, USA). After hybridization, the filters were washed under highly stringent conditions. The signals were analyzed with a Betascope-603.
Flow Cytometry, Antibodies and Immunofluorescence
The protocol is the same as previously published (3). Briefly, the monoclonal antibodies MRK-16 and 4E3 were used to detect the MDR1 P-glycoprotein. One hundred microliters of phosphate-buffered saline (PBS), without Ca 2+ or Mg 2+ (Sigma Chemical, St. Louis, MO, USA), containing 2 × 10 6 cells/tube and 1:1 dilution of human serum were incubated at 4°C for 30 min to inhibit nonspecific binding of antibodies. Two milliliters of PBS were then added to the cells, followed by centrifugation at 600 × gfor 5 min. The pelleted cells were resuspended in 100 µ L of PBS containing 1% bovine serum albumin (BSA) and 10 µ g/mL of the anti P-gp MAb or isotype-matched nonreactive control. This mixture was incubated for 30 min at 4°C, and the cells were washed twice with cold PBS followed by resuspension in 100 µ L of PBS containing 1% BSA and secondary antibody fluorescein isothiocyanate (FITC)-conjugated goat antimouse immunoglobulin (Becton Dickinson, Franklin Lakes, NJ, USA). The cells were incubated with the second antibody for 30 min at 4°C in the dark followed by two washes in cold PBS. The samples were then analyzed immediately, and the level of Pgp expression was determined by Kolmogorov-Smirnov analysis (14) using a FACScan ™ (Becton Dickinson) with Lysys II software as previously described (9) . The assay for the efflux of Rh-123 (Sigma Chemical) was performed as previously described ( ng/mL Rh-123 in 1 mL of RPMI-1640 medium at 37°C for 15 min, washed twice in ice cold medium, and then transferred into dye-free medium with or without 10 µ g/mL verapamil and incubated at 37°C for 90 min. The cell sorting method was reported previously (3), using CD34 and CD33 antigen as cell-surface markers for fluorescence-activated cell sorting (FACS). The fluorescence labeled antibodies HPCA-2 (anti-CD34) and CD33 were obtained from Becton Dickinson.
RESULTS
Comparison of Detection Methods for MDR1 RNA Levels
The cell lines Dox40 and Dox6 are known from previous work to express different levels of the MDR1 gene, Dox40 being significantly higher than Dox6 and CEM Dox1. The 8226/S, which is the parental cell line of Dox6 and Dox40, has no detectable MDR1 gene expression (3, 6) . The sensitivities of 32 P incorporation and QPCR were compared using Dox40 cells by removing separate reaction tubes from the thermal cycler at various cycle numbers and obtaining signals using each detection method. Figure 1 shows that a relatively strong signal was obtained from the QPCR method at cycle 25, but only a weak signal using 32 P incorporation (ratio 12:1). To evaluate accuracy, PCR template was diluted 1:10 five times and amplified by the two methods. Figure 2 shows that the signals from the QPCR method are closer to the expected values than those obtained by 32 P incorporation. To evaluate the reproducibility of the entire protocol, two experiments were performed using all three lines from which the same amount of cDNA was used in each reaction. Figure 3A shows that the standard deviation for QPCR ranged from 4% to 7% (mean 5.5 ± 1.9%), while it was 7% to 11% (mean 10.0 ± 3.3%) for the 32 P incorporation method ( Figure 3B ) ( P <0.001). The relative levels of MDR1 expression in cell lines were determined by Northern dot-blot analysis, 32 P-PCR and QPCR. Since the control gene for Northern blot ( β -actin) is different from β 2 -M used for PCR, we normalized the relative ratios with Dox40 set as 100%. Figure 4 shows that the MDR1 expression levels determined by QPCR are better correlated with the Northern-blot data than the 32 P results. The ratios of P-gp measured by flow cytometry in the system cell lines Dox40, Dox6 and 8226/S were 10.6 , 1.0 and 0, respectively, using the 4E3 and MRK-16 antibodies. The mRNA levels correlated well with the P-gp levels. Rhodamine efflux was 65%, 63% and 0% (in the presence or absence of verapamil). The QPCR ratio was 0.0072 for the CEMDox1 cell line, significantly (3-fold) above background (0.0018). The 32 P-PCR method failed to detect positivity (no difference with background), but flow cytometry of P-gp was positive using two different antibodies, as was the efflux study ( Figure 5) .
Comparison of the Detection Methods in AML Patient Samples
Three AML samples with blast counts of more than 95% were further enriched for blasts to 99% by FACS cell sorting. The P-gp levels for the blasts were determined by flow cytometry using the MDR1-specific monoclonal antibodies MRK-16 and 4E3. The efflux activities were also determined by Rh-123 dye retention in cells with or without verapamil. Figure 5 shows the P-gp levels (as D values), efflux activities and two quantitative PCR data in the three AML patient samples. The AML samples represent high, medium and low or negative P-gp levels and efflux activity. However, the 32 P incorporation method for quantitative PCR was unable to detect differences between those samples containing high and medium levels of P-gp: the ratios of MDR1/ β 2 -M were 0.41 and 0.40 (SD = 11%), respectively. In contrast, by using QPCR, differences were detected between the two levels of expression. The MDR1/ β 2 -M ratios were 0.127 and 0.097 (SD = 7%), respectively.
DISCUSSION
Quantitation of PCR is an important objective for many studies, and different techniques have been described (3, 6, 13) . As in any other quantitative technique, the more accurate, reproducible and sensitive the detection method, the better the results should be. The comparison between the nonradioactive, electrochemiluminescence-based QPCR method and 32 P incorporation as a means for measuring PCR products demonstrated that QPCR has increased sensitivity. This advantage may be important for allowing the detection of amplified products earlier in PCR, before a plateau phase is reached. The reproducibility was also better for QPCR than for the 32 P incorporation method, as determined by SD of 4% to 7% (mean 5.5) for QPCR, and 7% to 11% (mean 10.0) for 32 P incorporation PCR, respectively. In 32 P-PCR the samples are mixed with loading dye, and subsequently loaded on the gel. During this process, sample attachment to the loading tips could cause variations. The accuracy of QPCR also appeared to be better than that observed for the 32 P incorporation method, as evidenced by the correlation between the QPCR results, Northern-blot data, and the protein and functional results obtained by flow cytometry. The AML sample, considered negative by Rh123-efflux and P-gp antibody studies, was weakly positive by 32 P incorporation PCR, suggesting low levels of MDR1 mRNA. A very faint band was visible on autoradiographs, and the MDR1/ β 2 -M ratio of 0.12 suggested weak positivity. QPCR measurements, however, were 15-fold over background (ratio 0.0018) and 4-5-fold higher than the lower MDR1-expressing CEM Dox1 cell line (ratio 0.0072). While the significance of such low levels of MDR1 is not known, only a specific and sensitive technique will be able to answer this question. The QPCR system utilizes a biotin-labeled and a TBR-labeled primer, both of which are non-radioactive and as stable as regular unlabeled primers. In contrast, the use of a radioactive isotope may present problems in safety, handling, disposal and decay. Depending on the half-life of the isotope, the specific activity of the sample may be significantly affected during repetitions of experiments.
The time required for detecting PCR products using QPCR is 1 min per sample, with a prior 20-min bead-capture step that can be performed in batch. In contrast, the radioactivity method required the pouring and polymerization of a gel, electrophoresis and autoradiography, requiring a total time of approximately 8-12 h. The QPCR method is well suited for high-throughput applications using research and clinical samples.
